Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Recruiting · NCT04874428 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis | Digestive System Diseases, Embolism and Thrombosis, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cardiovascular disorder, cirrhosis of liver, liver disorder, vascular disorder, venous thromboembolism | Recruiting | Phase 1 | 2026-08-19 | NCT04874428 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire Vaudois | 62 |
| Insel Gruppe AG, University Hospital Bern | 224 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Visceral Surgery and Medicine, University Hospital Inselspital, Berne | Bern | Switzerland | 1 |